Eine Kamera ist auf eine reflektierende Glasscheibe gerichtet.
© DZIF

News

All current DZIF news can be found here.

Preisträger 2014
© DZIF

The first ever DZIF prize goes to a hepatitis researcher

(26/11/2014) Virologist Stephan Urban from the University of Heidelberg will receive the DZIF Prize for Translational Infection Research, worth 5000 Euros. It will be awarded for the first time at the

Peter Kremsner
© DZIF/scienceRelations

Ebola vaccine trial initiated in Gabon

Researchers at the University of Tübingen are testing an Ebola vaccine in healthy adults in Gabon. The first voluntary trial participants are being vaccinated today.

(18/11/2014) Clinical phase I

Focussing on Ebola virus
© Philipps-Universität Marburg

Ebola: Clinical trials for a safe vaccine

A clinical phase I trial for a potential vaccine against the dreaded Ebola virus can now begin. The candidate vaccine has already successfully been tested in different animal models. The trial is

Ulrich Nübel and his sequencer PacBio RSII
© DZIF

AAGGCTC: What genes reveal

For the population geneticist Ulrich Nübel almost everything revolves around gene sequences of bacterial strains. The scientist obtains a lot of information through analysing them: The course of

Ebola-Viren im Fokus
© Philipps-Universität Marburg

EBOKON: Strengthening Ebola Research

The German Center for Infection Research (DZIF) has initiated a consortium to strengthen Ebola research and close the knowledge gaps as quickly as possible in the fight against the epidemic. This

DZIF Researchers fight against Ebola

Professor Stephan Becker, Director of Marburg Virology and Coordinator of the DZIF Thematic Translational Unit “Emerging Infections”, is experienced in dealing with highly contagious viruses. At the

Tuberculosis bacteria
© CDC/James Archer

Tuberculosis: Better diagnosis in children

Rapid and reliable diagnosis of paediatric tuberculosis is still an ongoing problem. The most important prerequisite for successful treatment of active tuberculosis is its early diagnosis. A team of

DZIF participation in the ICAAC

For the first time, the DZIF participates in the ICAAC, the world's largest conference on antimicrobial agents and infectious diseases. The conference takes place from September 6 to 9 in Washington D

Dirk Busch und sein Team
© TUM/Astrid Eckert

Individual central memory T cells are "multipotent"

Researchers in Germany and the U.S. have proven for the first time that specific individual cells of the immune system, termed central memory T cells, have all the essential characteristics of adult

Marburger Sicherheitslabor
© DZIF/scienceRELATIONS

Coronaviruses: Getting to a vaccine as fast as possible

At the German Center for Infection Research (DZIF), researchers are working intensively to make available a vaccine against the dreaded MERS coronavirus as soon as possible. A candidate vaccine has